A carregar...
Optimizing outcomes with azacitidine: recommendations from Canadian centres of excellence
Myelodysplastic syndromes (mdss) constitute a heterogeneous group of malignant hematologic disorders characterized by marrow dysplasia, ineffective hematopoiesis, peripheral blood cytopenias, and pronounced risk of progression to acute myeloid leukemia. Azacitidine has emerged as an important treatm...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Multimed Inc.
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3921030/ https://ncbi.nlm.nih.gov/pubmed/24523604 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.21.1871 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|